top of page
Abstract Structure

Transaction and News

BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors

April 3, 2023 at 9:04:05 PM

Baijiayun to Acquire Beijing Hydrogen, an AI-enabled Marketing Service Provider in China

April 3, 2023 at 10:55:23 AM

TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China

March 29, 2023 at 9:04:23 AM

Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates

March 28, 2023 at 6:27:47 PM

Finnish Detection Technology To Acquire Chinese Haobo Imaging to Enter Flat Panel Detector Market

March 25, 2023 at 8:11:23 AM

China’s USI to Buy TE Connectivity’s Automotive Electronics Assets

March 22, 2023 at 4:03:31 PM

Abstract Structure
Collabrium Partners Logo

Company

Business

Legal

Location

Collabrium Partners & Co. Limited

9/F, Surson Commercial Building
140-142 Austin Road,
Tsim Sha Tsui, Kowloon,
Hong Kong

© 2019 Collabrium Partners & Co. Limited all rights reserved.

Mergers & Acquisitions
Strategic Advisory
Capital Restructuring
Private Placement
Special Committee
Independent Advice
Privacy Policy
Other Notices
Hong Kong
Beijing
Shanghai
Shenzhen
New York
London
Dubai
bottom of page